Hiroto Kuwabara

Medicine & Life Sciences

1. Positron-Emission Tomography 100%
2. Brain 65%
3. Corpus Striatum 47%
4. Dopamine 45%
5. Nicotinic Receptors 40%
6. fluorodopa F 18 30%
7. Raclopride 24%
8. Carboxy-Lyases 23%
9. 3-(1,4-diazabicyclo(3.2.2)nonan-4-yl)-6-fluorodibenzo(b,d)thiophene 5,5-dioxide 23%
10. Putamen 21%
11. Amphetamine 20%
12. Healthy Volunteers 20%
13. Dopamine Plasma Membrane Transport Proteins 19%
14. Papio 19%
15. Amyloid 19%
16. Parkinson Disease 19%
17. mu Opioid Receptor 18%
18. carfentanil 18%
19. Kinetics 17%
20. 2-(6-fluoro-2,3'-bipyridin-5'-yl)-7-methyl-7-azabicyclo(2.2.1)heptane 16%
21. Neuroimaging 16%
22. Oxygen 15%
23. White Matter 13%
24. Levodopa 13%
25. Dopamine Receptors 12%
26. 7-azabicyclo(2.2.1)heptane 12%
27. Hydrocortisone 12%
28. Alzheimer Disease 12%
29. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 12%
30. Serotonin Plasma Membrane Transport Proteins 11%
31. Serotonin 11%
32. Metabotropic Glutamate 5 Receptor 11%
33. Ligands 11%
34. Denervation 10%
35. Caudate Nucleus 10%
36. Cerebrovascular Circulation 10%
37. Short-Term Memory 10%
38. Glucose 10%
39. Opioid Receptors 10%
40. Ventral Striatum 10%
41. Dopamine D2 Receptors 9%
42. Alcohols 9%
43. Thalamus 9%
44. Decarboxylation 9%
45. Primates 9%
46. brexpiprazole 9%
47. Dopa Decarboxylase 9%
48. Stroke 9%
49. Molecular Imaging 8%
50. Hemodynamics 8%